WHO ICTRP trial
A Danger Signal, Uric Acid/ATP, Attracts and Activates Human Eosinophils
JPRN-UMIN000012185 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000012185 |
|---|---|
| Public title | A Danger Signal, Uric Acid/ATP, Attracts and Activates Human Eosinophils |
| Scientific title | A Danger Signal, Uric Acid/ATP, Attracts and Activates Human Eosinophils - Danger signal induced eosinophils activation |
| Primary sponsor | Saitama Medical University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Others,meta-analysis etc |
| Phase | Not selected |
| Countries | Japan |
| Conditions | bronchial asthma, eosinophilc pneumonia, Hypersensitivity Pneumonitis, sarcoidosis, pneumonia |
| Registration date | Oct 31, 2013 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: